Nanoparticle Antibiotic Delivery Systems for Specialized Environments

Publication ID: 24-11857679_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Nanoparticle Antibiotic Delivery Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857679_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857679_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,679.

Summary of the Inventive Concept

This inventive concept adapts nanoparticles carrying antibiotics for specific, narrow markets or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions, providing targeted solutions for combating antibiotic resistance.

Background and Problem Solved

The growing antibiotic resistance of harmful microbes has led to a pressing need for innovative drug delivery methods and systems. The original patent's nanoparticles carrying antibiotics addressed this issue, but its limitations in terms of environmental adaptability and accessibility necessitate further development for specialized contexts.

Detailed Description of the Inventive Concept

The new inventive concept involves designing and engineering nanoparticles carrying antibiotics tailored to specific, high-stakes environments. For instance, the system for delivering antibiotics in high-security environments comprises nanoparticles carrying antibiotics, a secure storage container, and a tracking device for monitoring the location and integrity of the nanoparticles. The method for treating infections in extreme weather conditions involves administering nanoparticles carrying antibiotics to a patient, and providing a portable, climate-controlled storage unit for storing the nanoparticles.

Novelty and Inventive Step

The new inventive concept's novelty lies in its adaptation of nanoparticles carrying antibiotics for specialized environments, introducing unique components and operational features that address specific challenges. The inventive step resides in the integration of these components to create targeted solutions that overcome the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include variations in nanoparticle composition, surface modification, or loading capacities to suit different environmental conditions. Other implementations could involve integrating nanoparticles with wearable devices, autonomous drones, or telemedicine platforms to enhance accessibility and monitoring.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including healthcare, biotechnology, and disaster relief. Target markets may include government agencies, hospitals, and private companies operating in high-security or extreme environments, as well as organizations focused on global health and humanitarian aid.

CPC Classifications

SectionClassGroup
A A61 A61K9/1075
A A61 A61K31/496
A A61 A61K47/20
A A61 A61K47/552
A A61 A61K47/58
A A61 A61K47/6907
A A61 A61P31/04

Field of Art

Pharmaceutical nanotechnology with a focus on drug delivery systems, specifically antibiotic encapsulation and targeted delivery technologies. Requires expertise in polymer chemistry, pharmaceutical formulation, and nanoscale engineering

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in pharmaceutical sciences, chemistry, or biomedical engineering, possessing knowledge of nanoparticle synthesis, drug encapsulation techniques, and medical delivery systems

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's nanoparticle antibiotic delivery method provides a foundational technology that can be readily adapted to specialized environments. The PTD's variations represent predictable extensions of the core nanoparticle technology, utilizing standard engineering design choices to address specific contextual challenges in drug delivery. The modifications involve integrating known components and applying standard engineering principles to enhance the utility of the base nanoparticle technology.

Obvious Combinations & Variations

Source Patent Element
Aqueous polyacrylate nanoparticle emulsions for encasing antibacterial compounds
PTD Variation
Integrating tracking devices and secure storage containers for high-security environments
Obviousness Reasoning
A PHOSITA would find it obvious to add tracking and secure storage as standard risk management techniques for sensitive medical technologies, representing a predictable solution to logistical challenges
Source Patent Element
Method of producing nanoparticle emulsions with specific temperature and solvent parameters
PTD Variation
Developing climate-controlled storage units for nanoparticle preservation in extreme environments
Obviousness Reasoning
Temperature sensitivity of nanoparticles is a known challenge, so creating specialized storage solutions represents a routine engineering adaptation with expected results
Source Patent Element
Nanoparticle drug delivery system for antibacterial compounds
PTD Variation
Incorporating telemedicine platforms and portable diagnostic devices for remote medical contexts
Obviousness Reasoning
Extending drug delivery technologies into telehealth represents a standard technological convergence, utilizing known communication and diagnostic technologies to enhance medical access
Source Patent Element
Polyacrylate nanoparticle emulsion techniques for drug encapsulation
PTD Variation
Modifying nanoparticle surface characteristics for specialized environmental interactions
Obviousness Reasoning
Surface modification of nanoparticles is a well-established technique, and adapting particle characteristics for specific environments represents a predictable design optimization
35 U.S.C. § 103 Summary: Based on US Patent 11857679's foundational nanoparticle antibiotic delivery methodology, the present publication demonstrates that the claimed variations represent obvious extensions readily apparent to a person having ordinary skill in pharmaceutical nanotechnology. The disclosed adaptations constitute straightforward technological modifications that would be predictable to a skilled practitioner, thereby rendering potential derivative claims non-patentable under standard obviousness criteria.

Original Patent Information

Patent NumberUS 11,857,679
TitleNanoparticles carrying antibiotics
Assignee(s)University of South Florida